We are excited to announce the launch of our latest medical device, Venus Heal™, now cleared in the United States to treat soft tissue injuries and conditions* faster than conventional methods.
February 5, 2019
TEL: (888) 907-0115
Venus Concept is a leader in the global medical and aesthetic device market, pairing best-in-class technology with the first and only true subscription model in the industry.
Soft tissue injuries are among the most common reasons patients seek care from sports medicine and rehabilitation specialists, with the goal, of course, to relieve pain, regain full movement, and strengthen the weakened area to prevent re-injury. While it may seem like a simple ask, the parameters around an injury and a slew of treatment options can make achieving these outcomes a complicated matter.
Fortunately, with the latest breakthroughs, ongoing educational opportunities, and treatment innovations, optimal treatment protocols are evolving to better heal these types of injuries. In fact, the potential for a full recovery to the patient’s previous quality of life and level of performance has markedly improved.
Here, we examine the latest advances offering the best treatments for soft tissue injuries today, including one of the newest modalities of note: Multi-Polar Radio Frequency (RF) and Pulsed Electro Magnetic Fields (PEMF), along with the added benefits of therapeutic massage.
Before we get into the technical details, it’s helpful to review the basics of soft tissue injuries.
Soft tissue injuries occur when muscles, ligaments, and/or tendons are exposed to direct or indirect trauma causing damage. Direct trauma may be caused by impact or abrupt overloading, while indirect trauma is tied to repeated sub-maximum loading, as with overuse injuries. Common symptoms include pain, swelling, and restricted movement. The four common types of soft tissue injuries are contusions (bruises), sprains, strains, and tendonitis.
Generally speaking, the healing of soft tissue injuries spans three phases: the acute inflammatory stage, lasting up to 72 hours; the repair stage, lasting from 48 hours to six weeks; and the remodeling stage, lasting from three weeks to a year or more.
The classic treatment protocol in the first three days following injury is to apply rest, ice, compression, and elevation (often abbreviated as “RICE”) to the injured area while avoiding the common “HARM” factors (heat, alcohol, running or exercise, and massage). This often relieves the initial symptoms.
To address the underlying injury, further treatment may focus on thermal or mechanical therapy. Energy-based devices, including ultrasound, transcutaneous electrical nerve stimulation (TENS), and cold laser, are used to address tissue pain, stiffness, and weakness. Therapies such as Active Release Techniques (ARTs), the Graston Technique, massage, and musculoskeletal manipulation/chiropractic techniques are occasionally used, too.
Unfortunately, due to common misconceptions regarding soft tissue injuries, some conditions receive no treatment and are left to heal on their own, though the reality is that healing, including remodeling of the tissue, can take a long time or never even occur if left untreated. In fact, one study found that only 12% of people with a soft tissue neck injury experienced complete recovery more than a decade after their accident, while another study of patients with whiplash found that 70% complained of symptoms related to the original injury 15.5 years afterward.
While minor injuries may resolve over time, many people experience residual and/or chronic symptoms, for which compensations in movement can lead to a cascade of other issues. This is why the rehabilitation community continues to seek advanced treatments for soft tissue injuries and conditions.
One of the newest advances in soft tissue injury treatments is the combination of Multi-Polar RF and PEMF to deliver synergistic benefits for reparation.
Separately, each of these modalities are well-validated approaches. Multi-Polar RF offers homogeneous deep-tissue heating resulting in tissue regeneration and remodeling, while PEMF induces an electro magnetic field in the target tissue, stimulating connective tissue, blood vessels, and muscles. Combined, they spur an increase in tissue metabolism, blood perfusion, lymphatic drainage, and the proliferation of new collagen, fibroblasts, tissue fibers, and blood vessels for accelerated healing and improved rehabilitation. When accompanied by massage, even more superior soft tissue injury rehabilitation may be achieved.
For further detail into how this treatment modality affects the targeted connective tissue, vascular networks, and muscles for accelerated reparation and rehabilitation, as well as a list of contraindications, download our latest report, Advances in the Treatment of Soft Tissue Injuries and Conditions: PEMF and Multi-Polar Radio Frequency.
For more information call: (888) 907-0115 // info@venusconcept.com // 235 Yorkland Blvd., Suite 900, Toronto, ON, M2J 4Y8 Canada
REGULATORY CLEARANCES [ More ]
Venus Bliss™ is cleared by the FDA and licensed by Health Canada for non-invasive lipolysis of the abdomen and flanks in individuals with a Body Mass Index (BMI) of 30 or less, with the diode laser applicators. The (MP)2 applicator is cleared by the FDA for temporary reduction in the appearance of cellulite, and licensed by Health Canada for temporary increase of skin tightening, temporary circumferential reduction, and temporary cellulite reduction. Venus Bliss™ has CE Mark as a non-invasive medical aesthetic device enabling a comprehensive approach leading to body contouring, addressing fat reduction, skin tightening, circumference reduction, and cellulite reduction.
Venus Versa™ is cleared by the FDA, licensed by Health Canada, and has CE Mark as a multi-application device intended to be used in aesthetic and cosmetic procedures. The SR515 and SR580 applicators are cleared by the FDA, licensed by Health Canada, and have CE Mark for the treatment of benign pigmented epidermal and cutaneous lesions and treatment of benign cutaneous vascular lesions. The HR650/HR650XL and HR690/HR690XL applicators are cleared by the FDA, licensed by Health Canada, and have CE Mark for the removal of unwanted hair and to effect stable long-term or permanent hair reduction for Fitzpatrick skin types I-IV. The AC Dual applicator is cleared by the FDA, licensed by Health Canada, and has CE Mark for the treatment of acne vulgaris. The DiamondPolar™ and OctiPolar™ applicators on the Venus Versa™ system are cleared by the FDA for non-invasive treatment of moderate to severe facial wrinkles and rhytides on females with Fitzpatrick skin types I-IV. The DiamondPolar™ applicator is licensed by Health Canada and has CE Mark for non-invasive treatment of moderate to severe facial wrinkles and rhytides on females with Fitzpatrick skin types I-IV. The OctiPolar™ applicator on the Venus Versa™ system is licensed by Health Canada and has CE Mark for temporary body contouring via skin tightening, circumferential reduction, and cellulite reduction. The NanoFractional RF™ (Viva) applicator is cleared by the FDA, licensed by Health Canada, and has CE Mark for dermatological procedures requiring ablation and resurfacing of the skin.
ARTAS iX™ is cleared by the FDA, licensed by Health Canada and has CE Mark with indication for use for harvesting hair follicles from the scalp in men diagnosed with androgenic alopecia (male pattern hair loss) who have black or brown straight hair. ARTAS iX™ is intended to assist physicians in identifying and extracting hair follicular units from the scalp during hair transplantation; creating recipient sites; and implanting harvested hair follicles.
NeoGraft® is cleared by the FDA, licensed by Health Canada and has CE Mark with indication for use in suction-assisted follicular extraction and re-implantation. NeoGraft® is an auto-graft system and can be used on both male and female patients.
Venus Legacy™ is cleared by the FDA for the non-invasive treatment of moderate to severe facial wrinkles and rhytides in females with Fitzpatrick skin types I-IV with the OctiPolar™ and DiamondPolar™ applicators, and temporary reduction in the appearance of cellulite with the 4D Body (LB2) and 4D Face (LF2) applicators. It is licensed by Health Canada and has CE Mark for the temporary increase of skin tightening, temporary circumferential reduction, temporary cellulite reduction, and temporary wrinkle reduction.
Venus Velocity™ is cleared by the FDA, licensed by Health Canada and has CE Mark for hair removal, permanent hair reduction (defined as the long-term stable reduction in the number of hairs re-growing when measured at 6, 9 and 12 months after the completion of a treatment regimen), and the treatment of pseudofolliculitis barbae for all Fitzpatrick skin types.
Venus Fiore™ received regulatory approval in Israel for aesthetic and functional treatment of the vagina, labia and mons pubis. Venus Fiore™ is available for sale in India, Hong Kong, and other selected Asian countries.
The Venus Viva™ MD is cleared by the FDA, licensed by Health Canada and has CE Mark for the use in dermatological procedures requiring ablation and resurfacing of the skin using the Viva™/Viva™ MD applicator, and the non-invasive treatment, reduction in the appearance of moderate to severe facial wrinkles and rhytides for females in Fitzpatrick skin types I-IV with the DiamondPolar™ applicator.
The Venus Viva™ MD is cleared by the FDA for the use in dermatological procedures requiring ablation and resurfacing of the skin, and the non-invasive treatment of moderate to severe facial wrinkles and rhytides for females in Fitzpatrick skin types I-IV with the DiamondPolar™ applicator.
Venus Epileve™ is cleared by FDA, licensed by Health Canada and has CE Mark for hair removal, permanent hair reduction (defined as the long-term stable reduction in the number of hairs re-growing when measured at 6, 9 and 12 months after the completion of a treatment regimen), and the treatment of pseudofolliculitis barbae for all Fitzpatrick skin types. Venus Epileve™ is also CE-Marked for hirsutism.
Venus Freeze Plus™ is cleared by the FDA for the non-invasive treatment of moderate to severe facial wrinkles and rhytides in females with Fitzpatrick skin types I-IV. It is licensed by Health Canada for temporary skin tightening, and temporary reduction in the appearance of cellulite on the abdomen and flanks, using the DiamondPolar™ and OctiPolar™ applicators. The DiamondPolar™ applicator on Venus Freeze Plus™ has CE Mark for the non-invasive treatment of moderate to severe facial wrinkles and rhytides, and the increase of skin tightening, temporary circumferential reduction, and cellulite reduction with the OctiPolar™ applicator.
Venus Heal™ is licensed by Health Canada and can be used for the treatment of both acute and chronic disorders of the musculoskeletal system, such as muscle spasms, back pain, and soft tissue injuries, and results in effects such as pain relief, myorelaxation, increase of local blood circulation, and edema reduction. In the U.S., Venus Heal™ is cleared by the FDA for the relief of minor muscle aches and pain, relief of muscle spasm, and temporary improvement of local blood circulation. These indications enable the treatment of certain soft tissue injuries and conditions.
Venus Glow™ is cleared by the FDA as a Class I motorized dermabrasion device. It provides a dermal rejuvenation treatment that works to open up and deep-clean pores. Venus Concept is the exclusive distributor for Venus Glow™.
Venus Skin™ is a skin care line of various lotions and creams intended to improve different aspects of skin appearance, skin serums, and skin nourishment solutions.
Copyright 2023 Venus Concept. All rights reserved.
You are entering our website. For other countries/regions and language options, please click the SELECT A DIFFERENT REGION button below.
SELECT A DIFFERENT REGIONAre you looking to get a treatment? Please visit our patient website to learn more.
Click HereBe aware of schemes involving fraudulent job postings.
Read More